- Open
- 0.88
- High
- 0.90
- Low
- 0.85
- Close
- 0.85
- Change
- -0.08 (-8.57%)
- Volume
- 3,109,586
| 1 Jul 2026 | 13:30:58 | Result of AGM |
| 11 Jun 2026 | 17:42:33 | Holding(s) in Company |
| 10 Jun 2026 | 16:53:21 | Holding(s) in Company |
| 8 Jun 2026 | 07:00:06 | Final Results |
| 4 Jun 2026 | 18:02:26 | Holding(s) in Company |
| 10 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 8 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 10 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
GENinCode is a company that focuses on assessing the risk of cardiovascular disease, which is the primary cause of death and disability globally. Their products utilize a combination of genetic and clinical data to provide healthcare professionals with advanced clinical information for patient risk assessment.
| 1 Jul 2026 | 13:30:58 | Result of AGM |
| 11 Jun 2026 | 17:42:33 | Holding(s) in Company |
| 10 Jun 2026 | 16:53:21 | Holding(s) in Company |
| 8 Jun 2026 | 07:00:06 | Final Results |
| 4 Jun 2026 | 18:02:26 | Holding(s) in Company |
| 10 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 8 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 10 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
GENinCode is a company that focuses on assessing the risk of cardiovascular disease, which is the primary cause of death and disability globally. Their products utilize a combination of genetic and clinical data to provide healthcare professionals with advanced clinical information for patient risk assessment.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £110m | +0.4% | |
| £56m | -0.4% | |
| £24m | +0.5% | |
| £10m | +0.2% | |
GENIGenincode PLC | £6m | -0.5% |
| £1m | — |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £110m | +0.4% | |
| £56m | -0.4% | |
| £24m | +0.5% | |
| £10m | +0.2% | |
GENIGenincode PLC | £6m | -0.5% |
| £1m | — |
